Onkologie. 2024:18(1):43-47 | DOI: 10.36290/xon.2024.009

Surgical treatment of endometrial cancer

Dominik Karásek¹, Munachiso Ndukwe¹, Ivan Práznovec¹, Jiří Špaček¹, Denisa Pohanková², Igor Sirák²

¹ Porodnická a gynekologická klinika Fakultní nemocnice Hradec Králové, Lékařská fakulta v Hradci Králové Univerzita Karlova

² Klinika onkologie a radioterapie, Univerzita Karlova, Lékařská fakulta v Hradci Králové a Fakultní nemocnice, Hradec Králové

Endometrial cancer is the most common gynecological malignancy in resource-abundant countries. Prevalence grows with age and it is more frequent among obese women. It tends to have relatively low mortality, because of its early presentation and diagnosis in early stages of disease, when it is confined to the uterus. In the last decade, we can observe a decline in the open abdominal surgical approach and a rise and dominance of minimally invasive approaches to surgical staging, those combined with lymph nodes evaluation provide an alternative to previous surgical management with no compromise to the onco-gynecological outcomes. Recently, a new surgical staging system for endometrial cancer has been introduced by the International Federation of Gynecology and Obstetrics, which includes the molecular classification and shall better define prognostic groups to ensure optimal treatment.

Keywords: endometrial cancer, minimally invasive surgery in gynecology, FIGO 2023, surgical staging, molecular classification.

Accepted: February 22, 2024; Published: February 28, 2024  Show citation